Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Diagnostic performance of dedicated breast positron emission tomography in cases of histology-unknown abnormal uptake, and parameters associated with breast cancer

Yoko Satoh
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 416;
Yoko Satoh
1Yamanashi PET imaging clinic Chuo Japan
2Radiology Yamanashi University Chuo, Yamanashi Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

Tables

  • Figures
  • Characteristics of abnormal FDG uptake on dbPET and comparison between breast cancer and others 1

    Cancers (n = 13)Others (n = 27)p value
    Age (years)Mean ± SD57.54 ± 12.5749.96 ± 10.750.1785
    Menopausal statePre7160.7457
    History of breast cancer(+)560.2813
    Family history of breast cancer(+)351.000
    Breast symptom/s (except for known cancer)(+)650.0667
    Prior MMG and/or US within 1.5 years(+)9230.4371
  • Characteristics of abnormal FDG uptake on dbPET and comparison between breast cancer and others 2

    Cancers (n = 13)Others (n = 27)p value
    Uptake findings on dbPETFocus1150.0122[asterisk]
    Mass1011
    Non- mass21
    SUVmaxMean ± SD6.887 ± 4.8164.77 ± 2.3940.1794
    SUVpeakMean ± SD3.521 ± 2.3872.001 ± 0.7740.0234[asterisk]
    TLGMean ± SD6.238 ± 15.3190.851 ± 1.4680.0017[asterisk]
    MTVMean ± SD0.977 ± 1.6390.331±0.5590.0040[asterisk]
    L/BMean ± SD3.165 ± 2.9161.873±1.0860.0432[asterisk]
  • Multivariate logistic regression analysis of characteristics related to breast cancer

    Odds ratio (95% CI)p value
    Uptake findings on dbPETFocus/Mass9.631 (1.366, 197.076)0.0209[asterisk]
    Non-mass/Focus0.0794
    Mass/Non-mass0.6446
    TLG0.2805
    L/B0.4771
  • Characteristics of breast ca. detected by dbPET

    Histological characteristicn=13
    TypeIDC/DCIS7/6
    SubtypeLuminal/HER2 rich/unknown10/1/2
    T stageTis6
    T1(T1a/T1b/T1c)4(1/1/2)
    T23
    Nodal statusositive/Negative2/11
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic performance of dedicated breast positron emission tomography in cases of histology-unknown abnormal uptake, and parameters associated with breast cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Diagnostic performance of dedicated breast positron emission tomography in cases of histology-unknown abnormal uptake, and parameters associated with breast cancer
Yoko Satoh
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 416;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diagnostic performance of dedicated breast positron emission tomography in cases of histology-unknown abnormal uptake, and parameters associated with breast cancer
Yoko Satoh
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 416;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Breast Cancer: Detection and Staging

  • Positron Emission Mammography in management of new diagnosed breast cancer routine management
  • Post Injection Pain During Breast Lymphoscintigraphy: Technetium Sulfur Colloid versus Technetium Tilmanocept
Show more Breast Cancer: Detection and Staging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire